Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1463 to 1512 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1463\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
pnas-18. [source:sptrembl;acc:q9bzu3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
161.056\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
164.211\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01959\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1464\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
poly (adp-ribose) glycohydrolase. [source:refseq;acc:nm\_003631]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.351\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.18\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01957\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1465\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mto1 protein homolog (cgi-02). [source:swissprot;acc:q9y2z2]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1466\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RTN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
reticulon protein 2 (neuroendocrine-specific protein-like 1) (nsp-like protein 1) (nspli). [source:swissprot;acc:o75298]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.073\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1467\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MPP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
maguk p55 subfamily member 2 (mpp2 protein) (discs, large homolog 2). [source:swissprot;acc:q14168]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.513\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.983\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01956\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1468\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DRAP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dr1-associated protein 1; negative cofactor 2 alpha; dr1-associated corepressor. [source:refseq;acc:nm\_006442]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.937\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01954\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1469\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RTN3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
reticulon protein 3 (neuroendocrine-specific protein-like 2) (nsp-like protein ii) (nsplii). [source:swissprot;acc:o95197]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0195\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1470\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
QARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutaminyl-trna synthetase (ec 6.1.1.18) (glutamine--trna ligase) (glnrs). [source:swissprot;acc:p47897]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.412\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.199\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0194\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1471\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRM\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
spermidine synthase (ec 2.5.1.16) (putrescine aminopropyltransferase) (spdsy). [source:swissprot;acc:p19623]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycyl-trna synthetase (ec 6.1.1.14) (glycine--trna ligase) (glyrs). [source:swissprot;acc:p41250]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1473\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EARS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamyl trna synthetase. [source:sptrembl;acc:o14563]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1474\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RANBP5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
importin beta-3 subunit (karyopherin beta-3 subunit) (ran-binding protein 5). [source:swissprot;acc:o00410]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.427\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01938\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1475\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KYNU\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kynureninase (ec 3.7.1.3) (l-kynurenine hydrolase). [source:swissprot;acc:q16719]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.882\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0193\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1476\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RANBP6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ran-gtp binding protein (fragment). [source:sptrembl;acc:o60518]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.591\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.457\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1477\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transformer-2 protein homolog (tra-2 alpha). [source:swissprot;acc:q13595]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.328\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.267\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01922\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1478\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SFRS10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.122\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.066\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MPP6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
maguk p55 subfamily member 6 (veli-associated maguk 1) (vam-1). [source:swissprot;acc:q9nzw5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.855\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1480\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPSF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 6, 68 kd subunit; pre-mrna cleavage factor im (68kd); cleavage and polyadenylation specific factor 6, 68kd subunit; pre-mrna cleavage factor i, 68kd subunit. [source:refseq;acc:nm\_007007]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01918\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC23\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cell division cycle protein 23; anaphase-promoting complex subunit 8. [source:refseq;acc:nm\_004661]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.516\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01915\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1482\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LSAMP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
limbic system-associated membrane protein precursor (lsamp). [source:swissprot;acc:q13449]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.15\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0191\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1483\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDHB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component beta subunit, mitochondrial precursor (ec 1.2.4.1) (pdhe1-b). [source:swissprot;acc:p11177]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
198.927\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.726\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1484\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMEM91\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2-oxoisovalerate dehydrogenase alpha subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component alpha chain) (bckdh e1-alpha). [source:swissprot;acc:p12694]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1485\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBPJ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
j kappa-recombination signal binding protein (rbp-j kappa). [source:swissprot;acc:q06330]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
207.877\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.989\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01906\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1486\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIVEP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer binding protein 3. [source:refseq;acc:nm\_024503]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1487\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIVEP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 40 (human immunodeficiency virus type i enhancer- binding protein 1) (hiv-ep1) (major histocompatibility complex binding protein 1) (mbp-1) (positive regulatory domain ii binding factor 1) (prdii-bf1). [source:swissprot;acc:p15822]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1488\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIVEP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer-binding protein 2 (hiv-ep2). [source:swissprot;acc:p31629]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1489\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAP3K7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 (ec 2.7.1.-) (transforming growth factor-beta-activated kinase 1) (tgf-beta- activated kinase 1). [source:swissprot;acc:o43318]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.264\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01905\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1490\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PTRH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-147. [source:swissprot;acc:q9y3e5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.186\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01903\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1491\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GPI\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glucose-6-phosphate isomerase (ec 5.3.1.9) (gpi) (phosphoglucose isomerase) (pgi) (phosphohexose isomerase) (phi) (neuroleukin) (nlk) (sperm antigen-36) (sa-36). [source:swissprot;acc:p06744]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.704\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.839\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01899\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1492\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OPCML\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
opioid binding protein/cell adhesion molecule precursor (obcam) (opioid-binding cell adhesion molecule) (opcml). [source:swissprot;acc:q14982]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.017\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01883\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1493\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDHA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, testis-specific form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type ii). [source:swissprot;acc:p29803]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.988\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01882\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1494\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDHA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, somatic form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type i). [source:swissprot;acc:p08559]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.133\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.967\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01878\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1495\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK1A1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.459\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
225.237\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01874\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1496\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK1A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase i, alpha isoform (ec 2.7.1.-) (cki-alpha) (ck1). [source:swissprot;acc:p48729]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1497\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
XPO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exportin 1; exportin-1 (required for chromosome region maintenance); exportin 1 (crm1, yeast, homolog); crm1, yeast, homolog. [source:refseq;acc:nm\_003400]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.476\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.363\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01866\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1498\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neurotrimin precursor (hnt). [source:swissprot;acc:q9p121]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.022\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.924\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01863\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1499\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DCP1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor smif; decapping enzyme hdcp1a. [source:refseq;acc:nm\_018403]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.509\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.411\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01859\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1500\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COPS4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cop9 complex subunit 4; likely ortholog of mouse cop9 (constitutive photomorphogenic), subunit 4 (arabidopsis); cop9 (constitutive photomorphogenic, arabidopsis, homolog) subunit 4. [source:refseq;acc:nm\_016129]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.398\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01851\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1501\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIFC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kinesin family member c3. [source:refseq;acc:nm\_005550]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.727\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.838\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01845\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
uridine kinase-like 1. [source:swissprot;acc:q9nwz5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.084\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.149\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01838\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KRR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hiv-1 rev binding protein 2; rev interacting protein. [source:refseq;acc:nm\_007043]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
237.834\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01828\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC25C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
m-phase inducer phosphatase 3 (ec 3.1.3.48) (dual specificity phosphatase cdc25c). [source:swissprot;acc:p30307]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
259.439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.797\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01822\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCDC53\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein ad-016 (protein cgi-116) (x0009). [source:swissprot;acc:q9y3c0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.158\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.316\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0181\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1506\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C16orf42\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c316g12.2 (novel protein similar to predicted yeast, worm and archae- bacterial proteins) (similar to und313) (s. cervisiae) (hypothetical protein). [source:sptrembl;acc:q9ujk0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.103\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.339\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1507\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
[pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precursor (ec 2.7.1.99) (pyruvate dehydrogenase kinase isoform 1). [source:swissprot;acc:q15118]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.274\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01801\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1508\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
[pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial precursor (ec 2.7.1.99) (pyruvate dehydrogenase kinase isoform 2). [source:swissprot;acc:q15119]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1509\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTR1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-centractin (centractin) (centrosome-associated actin homolog) (actin-rpv) (arp1). [source:swissprot;acc:p42024]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.148\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.177\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01795\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1510\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTR1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
beta-centractin (actin-related protein 1b) (arp1b). [source:swissprot;acc:p42025]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1511\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COX11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome c oxidase assembly protein cox11, mitochondrial precursor. [source:swissprot;acc:q9y6n1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.268\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.509\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01794\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1512\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SURF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
surfeit locus protein 1. [source:swissprot;acc:q15526]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/